Healthcare Industry Insights

Tuesday, 18 February 2020

Protein Extracts from Single Cell Protein and Other Conventional Sources Market Worth $26.3 Billion By 2025

The global Protein Extracts From Single Cell Protein And Other Conventional Sources Market size is expected to reach USD 26.3 billion by 2025, according to a new report by Grand View Research, Inc. Registering an 8.4% CAGR during the forecast period, the market is expected to be driven by rising investments in the animal feed industry to cater to rising demand for cattle feed.

India ranks first with respect to cattle inventory, with demand for cattle inventory constantly increasing in U.S. This is driving demand for animal feed and protein extracts from different sources. In U.S., approximately 12.0% of the cattle inventory falls under drought area. This percentage was approximately 73.0% and 26.0% in 2013 and 2008, respectively.

Furthermore, the combination of genetic engineering techniques to produce proteins and attain better expression levels is expected to boost this market. These genetic modifications aid in increasing nutraceutical value of the biomass product either by increasing amino acid composition or by optimization of other biomolecules present in the product. Moreover, there are a number of methods for the removal of ribonucleic acid (RNA) from extracted protein, another factor likely to impact market growth.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/protein-extracts-from-single-cell-protein-other-conventional-sources-market

Further key findings from the report suggest:

Market penetration of protein extracts in pharmaceuticals and nutraceuticals is highest in the market and consequently, these segments accounted for a larger share in 2016
Animal feed protein extracts and agricultural protein extracts are anticipated to grow at a similar pace in the coming years owing to rising demand for proteins in these sectors. Traditional protein sources have been inadequate in catering to growing demand
Plant protein sources accounted for the largest share owing to easy availability. However, SCP-based extracts are anticipated to grow at lucrative rate environmental concerns play a strong role in driving the development of novel SCP products
North America accounts for the largest share in the protein extracts market with respect to pharmaceutical applications. Presence of well-established companies engaged in feed production through microbial cell cultivation have attributed to its growth
Ongoing research studies in U.S. regarding use of microbes as an alternative nutrient source is expected to propel the growth of this regional market during the forecast period
Asia Pacific accounted for the largest share in protein extract consumption with regard to animal feed. In recent times, universities and industries in China have been observed to be significantly active in filing patents related to SCP. This is sure to have a positive impact on regional growth
Some of the prominent players in the market are Nutreco; AgriProtein Holdings; ZEN-NOH; KnipBio; BlueBioTech Int. GmbH; Lallemand Inc.; and Marlow Foods Limited.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Vaccine Contract Manufacturing Market Trends and Growth Opportunities

The global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.

Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.

Increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered “strategic competitive weapons” among vaccine manufacturers as they help overcome the aforementioned issues.

A number of international healthcare organizations are engaged in estimating and predicting the quantity of goods as well as financial need required for conducting immunization programs. Some of the factors considered for this estimation are quantity of vaccines, estimated time of delivery, product type, and vial size. Participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/vaccine-contract-manufacturing-market

Further key findings from the report suggest:

Contract services for development of attenuated vaccines accounted for the major share in the market based on vaccine type. This can be attributed to the fact that these vaccines offer immunity for a lifetime with only one or two doses
DNA vaccines form the fastest-growing segment by type, with several kinds already being tested on humans
Based on workflow, downstream processing dominated the market mainly due to the necessity of mature and reliable biotechnology tools for product recovery. Various research initiatives in the space are also contributing in advancing downstream workflows
By application, contract services for the development of human-use vaccines held the largest share owing to their high adoption to develop vaccines against influenza and other illnesses
Lonza; IDT Biologika GmbH; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; and Merck KGaA are some of the major players offering services for vaccine development.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Local Anesthesia Drugs Market Trends, Analysis, Growth and Outlook Report, 2025

The global Local Anesthesia Drugs Market size is anticipated to reach USD 6.45 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.7% CAGR during the forecast period. Rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

Introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market

Further key findings from the study suggest:

Lidocaine dominated the market by product as of 2016 owing to its extensive use as topical and injectable anesthetic
By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems is expected to drive the market for surface anesthetics over the forecast period
North America held the largest share in the market for local anesthesia drugs owing to significant number of surgical procedures performed in the region
Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.

Neglected Tropical Disease Diagnosis Market Analysis Report, 2025

The global Neglected Tropical Diseases Diagnosis Market size is expected to reach USD 7.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 4.1% CAGR during the forecast period. The combined effect of high impact factors such as soaring disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Rising concern regarding Neglected Tropical Diseases (NTD) and its global impact on population as well as governments has fueled demand for development of early disease detection methods. This growth in concern is evident by launch of a substantial number of programs aiming to combat NTDs.

For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market

Further key findings from the report suggest:

By disease type, dengue captured the largest share over other NTDs in 2016. Growing dengue cases and development of novel products for its diagnosis is expected to help this segment maintain its dominance in the coming years
Conventional diagnostic methods accounted for the majority share owing to high market penetration of these techniques, including pathogen culturing, biochemical methods, gram staining, and serology tests
Molecular/modern diagnostic methods are growing at a lucrative pace and are expected to supplant conventional techniques in the coming years. This is majorly due to the advantages of molecular tests with respect to accuracy, specificity, and timelines
Centralized services held the largest share in 2016 owing to easy access to these services; however, point-of-care testing (POCT) services are anticipated exhibit lucrative growth in the coming years owing to benefits such as portability and ease of use
By end use, home healthcare is expected to be the fastest growing segment as a result of growing popularity and demand for POCT services
Asia Pacific is estimated to be the largest regional market and is expected to maintain its position throughout the forecast period thanks to constant growth in GDP, presence of a large target population, and high prevalence of neglected tropical diseases in the region
Abbott; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; and Omega Diagnostics Group PLC are some of the key players operating in this market.

Monday, 17 February 2020

Insomnia Therapeutics Market Analysis Report by Treatment, 2025

The global Insomnia Therapeutics Market is expected to reach USD 3.45 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/insomnia-therapeutics-market

Further Key Findings From the Report Suggest:

North America held majority of the share in 2016 due to increase inawareness about diseases, growing geriatricpopulation, and high adoption of therapeutics for treatment.
The U.S. dominated North America owing to the presence of largest sleep-deprived population and use of patented drugs for treatment.
Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.
Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co, Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co., Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb Therapeutics.

Personal Emergency Response Systems Market Research Report 2018– 2025

The global PERS market is estimated to reach USD 11.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of Alzheimer’s disease and rising life expectancy are estimated to boost the market for Medical alert systems. Moreover, increasing number of mergers and acquisitions by market players are also expected to accelerate growth.

Furthermore, the elderly is more prone to falls, and according to a study, 50% of seniors aged 80 years and 30% of seniors aged 65 fall every year. In addition, those suffering from diseases such as epilepsy, Alzheimer’s, Parkinson’s, multiple sclerosis, and muscular dystrophy, are at a higher risk of falling. These are major factors that are estimated to drive the market.

In addition, availability of technologically advanced medical alert systems, such as those enabled with W-Fi, GPS, BLE, and radio frequency, help caregivers in finding wandering elders. Combination of PERS with mobile communication technology has enabled not only monitoring of users when they are at home, but also when they are traveling and leading active lives. Devices are now capable of predictive or automatic fall detection and connect the elderly to their caregivers and medical professionals. Increasing awareness about Internet of Things has presented a huge opportunity for medical alert systems to create connected homes. Thus, technologically advanced PERS devices have accelerated the growth of the market.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/medical-alert-personal-emergency-response-system-pers-market

Further Key Findings From the Report Suggest:

Standalone devices are expected to be one of the fastest growing segments over the forecast period owing to their accessibility and affordability
Mobile systems were the largest segment in 2016 due to their widespread utilization

Home-based users segment is estimated to be the fastest growing end-use segment over the forecast period and it was the largest end-use segment in 2016

North America dominated the market in 2016 owing to local presence of key players and increasing number of mergers and acquisitions
Asia Pacific is expected to be the fastest growing region over the next decade with a lucrative CAGR from 2017 to 2025 due to improved economic conditions and rise in healthcare expenditure
Some of the key players are Koninklijke Philips N.V.; ADT Security Services; Bay Alarm Medical; VRI, Inc.; Life Alert Emergency Response, Inc.; Tunstall; Medical Guardian LLC; AlertOne Services LLC; GreatCall; Rescue Alert; LogicMark; and Nortek Security and Control
Most of the key players are focusing on expanding their product portfolios, and engaging in collaborations and acquisitions

Non-vascular Stents Market Trends, Analysis, Growth and Outlook Report, 2025

The global Non-Vascular Stents Market is anticipated to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in adoption of minimally invasive surgeries across the world.

Technological advancements such as development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy(cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per requirement as they offer different features.

Due to high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/non-vascular-stents-market

Further Key Findings From the Study Suggest:

The urological stents segment held a lucrative market share in 2016 owing to worldwide increase in demand for ureteral, and prostate stents, which can be attributed to the surge in number of kidney transplants, ureteroscopy, ureterorenoscopy, lithotripsy, and schistosomiasis procedures
The gastrointestinal stents segment is expected to register highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with high prevalence of gastrointestinal cancer in the U.S. & Canada
Some of the key players in the market are Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; and Glaukos Corporation

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com